Proton Therapy Publication Proton Therapy Publication
Menu

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation

December 2020
Executive summary

A cohort of 30 patients was retrospectively selected as "at-risk" of dose de-escalation due to the proximity of the target volumes to dose-limiting healthy structures. IMPT plans were compared to volumetric modulated arc therapy (VMAT) RapidArc (RA) plans. The maximum dose prescription foreseen was 75 Gy in 3 fractions.

This plan comparison study found that IMPT and VMAT plans resulted in equivalent target dose for CTV and PTV, however significant improvements were observed with IMPT for all organs at risk such as the ribs, chest wall, heart, duodenum, stomach and bowel bag. Twenty patients violated one or more binding constraints with RA, while only 2 with IMPT. Some dose de-intensification would have been required to respect the constraints. IMPT might result in advantages compared to photon-based VMAT for HCC patients to be treated with ablative SBRT in mitigating the risk of dose de-escalation.

Key content topics
VMAT
IMPT
Top cancer treatments
Gastro-intestinal

Related contents

Proton Therapy Publication
March 2024
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.
en
Link to the fully detailed content
Proton Therapy Publication
December 2023
Comparison of the Effectiveness of Radiotherapy with 3D-CRT, IMRT, VMAT and PT for Newly Diagnosed Glioblastoma: A Bayesian Network Meta-Analysis.
en
Link to the fully detailed content
Proton Therapy Publication
February 2022
A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
en
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
January 2022
Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
December 2021
A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
Link to the fully detailed content
Proton Therapy Publication
July 2021
Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
en
Link to the fully detailed content
Proton Therapy Publication
July 2021
Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
en
Link to the fully detailed content